US Stock MarketDetailed Quotes

TRAW Traws Pharma

Watchlist
  • 2.460
  • -0.850-25.68%
Trading Mar 3 12:08 ET
8.98MMarket Cap-0.02P/E (TTM)

About Traws Pharma Company

Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.

Company Profile

SymbolTRAW
Company NameTraws Pharma
Listing DateJul 25, 2013
Founded1998
CEOMr. Werner Cautreels PhD
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address12 Penns Trail
CityNewtown
ProvincePennsylvania
CountryUnited States of America
Zip Code18940-3423
Phone1-267-759-3680
Websitehttp://www.trawspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Werner Cautreels, PhD
  • Director and Chief Executive Officer
  • --
  • Dr. Robert Redfield
  • Chief Medical Officer
  • --
  • Nora E. Brennan
  • Interim Chief Financial Officer
  • --
  • Dr. Nikolay Savchuk
  • Director and Chief Operating Officer
  • --
  • Dr. Charles David Pauza, PhD
  • Chief Scientific Officer, Virology
  • --
  • Dr. Victor M. Moyo, M.D.
  • Chief Medical Officer, Oncology
  • 405.24K
  • Dr. Iain D. Dukes, D.Phil.
  • Executive Chairman of the Board
  • --
  • Jack E. Stover
  • Independent Director
  • 126.72K
  • Dr. Trafford Clarke, PhD
  • Independent Director
  • 104.22K
  • Mary Teresa Shoemaker
  • Independent Director
  • 118.22K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Shanghai Mobitech Technology
301173
+149.17%
WUHAN LAND
830779
+30.00%
BAWEI
837023
+29.99%
4
LWGF
831627
+29.99%
5
POWER GLORY TECH
835237
+29.99%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!